177 related articles for article (PubMed ID: 24365145)
1. Viral hybrid-vectors for delivery of autonomous replicons.
Zhang W; Hagedorn C; Schulz E; Lipps HJ; Ehrhardt A
Curr Gene Ther; 2014 Feb; 14(1):10-23. PubMed ID: 24365145
[TBL] [Abstract][Full Text] [Related]
2. Sleeping Beauty-baculovirus hybrid vectors for long-term gene expression in the eye.
Turunen TA; Laakkonen JP; Alasaarela L; Airenne KJ; Ylä-Herttuala S
J Gene Med; 2014; 16(1-2):40-53. PubMed ID: 24464652
[TBL] [Abstract][Full Text] [Related]
3. Stable transduction of actively dividing cells via a novel adenoviral/episomal vector.
Leblois H; Roche C; Di Falco N; Orsini C; Yeh P; Perricaudet M
Mol Ther; 2000 Apr; 1(4):314-22. PubMed ID: 10933949
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus type 1 amplicons and their hybrid virus partners, EBV, AAV, and retrovirus.
Oehmig A; Fraefel C; Breakefield XO; Ackermann M
Curr Gene Ther; 2004 Dec; 4(4):385-408. PubMed ID: 15578989
[TBL] [Abstract][Full Text] [Related]
5. Integrase-defective lentiviral vectors--a stage for nonviral integration machineries.
Staunstrup NH; Mikkelsen JG
Curr Gene Ther; 2011 Oct; 11(5):350-62. PubMed ID: 21745178
[TBL] [Abstract][Full Text] [Related]
6. Prolonged transgene expression in glomeruli using an EBV replicon vector system combined with HVJ liposomes.
Tsujie M; Isaka Y; Nakamura H; Kaneda Y; Imai E; Hori M
Kidney Int; 2001 Apr; 59(4):1390-6. PubMed ID: 11260400
[TBL] [Abstract][Full Text] [Related]
7. EBV replicon vector system enhances transgene expression in vivo: applications to cancer gene therapy.
Otomo T; Yamamoto S; Morishita R; Kaneda Y
J Gene Med; 2001; 3(4):345-52. PubMed ID: 11529664
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.
Philippe S; Sarkis C; Barkats M; Mammeri H; Ladroue C; Petit C; Mallet J; Serguera C
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17684-9. PubMed ID: 17095605
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Preclinical Developments Using Adenovirus Hybrid Vectors.
Ehrke-Schulz E; Zhang W; Gao J; Ehrhardt A
Hum Gene Ther; 2017 Oct; 28(10):833-841. PubMed ID: 28854818
[TBL] [Abstract][Full Text] [Related]
10. Foamy virus-adenovirus hybrid vectors for gene therapy of the arthritides.
Weber C; Armbruster N; Scheller C; Kreppel F; Kochanek S; Rethwilm A; Steinert AF
J Gene Med; 2013; 15(3-4):155-67. PubMed ID: 23554302
[TBL] [Abstract][Full Text] [Related]
11. Development of herpesvirus-based episomally maintained gene delivery vectors.
Calderwood MA; White RE; Whitehouse A
Expert Opin Biol Ther; 2004 Apr; 4(4):493-505. PubMed ID: 15102599
[TBL] [Abstract][Full Text] [Related]
12. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes.
Saeki Y; Wataya-Kaneda M; Tanaka K; Kaneda Y
Gene Ther; 1998 Aug; 5(8):1031-7. PubMed ID: 10326025
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells.
Dorigo O; Gil JS; Gallaher SD; Tan BT; Castro MG; Lowenstein PR; Calos MP; Berk AJ
J Virol; 2004 Jun; 78(12):6556-66. PubMed ID: 15163748
[TBL] [Abstract][Full Text] [Related]
14. Targeted transgene insertion into the CHO cell genome using Cre recombinase-incorporating integrase-defective retroviral vectors.
Kawabe Y; Shimomura T; Huang S; Imanishi S; Ito A; Kamihira M
Biotechnol Bioeng; 2016 Jul; 113(7):1600-10. PubMed ID: 26724679
[TBL] [Abstract][Full Text] [Related]
15. Episomal vectors for gene therapy.
Ehrhardt A; Haase R; Schepers A; Deutsch MJ; Lipps HJ; Baiker A
Curr Gene Ther; 2008 Jun; 8(3):147-61. PubMed ID: 18537590
[TBL] [Abstract][Full Text] [Related]
16. Replicon-based vectors of positive strand RNA viruses.
Khromykh AA
Curr Opin Mol Ther; 2000 Oct; 2(5):555-69. PubMed ID: 11249758
[TBL] [Abstract][Full Text] [Related]
17. Development of adenovirus hybrid vectors for Sleeping Beauty transposition in large mammals.
Hausl M; Zhang W; Voigtländer R; Müther N; Rauschhuber C; Ehrhardt A
Curr Gene Ther; 2011 Oct; 11(5):363-74. PubMed ID: 21888620
[TBL] [Abstract][Full Text] [Related]
18. Replicon vectors derived from Sindbis virus and Semliki forest virus that establish persistent replication in host cells.
Perri S; Driver DA; Gardner JP; Sherrill S; Belli BA; Dubensky TW; Polo JM
J Virol; 2000 Oct; 74(20):9802-7. PubMed ID: 11000258
[TBL] [Abstract][Full Text] [Related]
19. Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors.
Mazda O
Curr Gene Ther; 2002 Sep; 2(3):379-92. PubMed ID: 12189722
[TBL] [Abstract][Full Text] [Related]
20. Self-focusing therapeutic gene delivery with intelligent gene vector swarms: intra-swarm signalling through receptor transgene expression in targeted cells.
Tolmachov OE
Artif Intell Med; 2015 Jan; 63(1):1-6. PubMed ID: 25547266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
